Stocksigma LogoStocksigma Logo

Thyrocare Technologies Reports Robust Q2FY27 Results with 25.1% YoY Revenue Growth

Thyrocare Technologies reported consolidated revenue of INR 270.8 Cr for Q2FY27, up 25.1% YoY, driven by a 26.7% YoY increase in Pathology

Thyrocare Technologies Reports Robust Q2FY27 Results with 25.1% YoY Revenue Growth

Thyrocare Technologies Ltd 路 Press Release 路 29 Oct 2026, 9:40 pm

Thyrocare Technologies Reports Robust Q2FY27 Results with 25.1% YoY Revenue Growth Thyrocare Technologies reported consolidated revenue of INR 270.8 Cr for Q2FY27, up 25.1% YoY, driven by a 26.7% YoY increase in Pathology. EBITDA grew 24.9% YoY to INR 89.3 Cr, while PAT before exceptional items rose 25.7% YoY to INR 60.2 Cr. Reported PAT stood at INR 15.2 Cr due to a one-time non-cash impairment of INR 45 Cr related to the proposed divestment of the NHL business. Test volumes rose 27.4% YoY to 61.6 million, supported by 12,911 active franchisees.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements